Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.

被引:0
|
作者
Wang, Xiuchao [1 ]
Wang, Hongwei [1 ]
Chen, Xinyun [1 ]
Liu, Yuxiao [1 ]
Zhao, Tiansuo [1 ]
Gao, Song [1 ]
Wang, Jian [1 ]
Ma, Weidong [1 ]
Gao, Chuntao [1 ]
Hao, Jihui [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
744
引用
收藏
页码:744 / 744
页数:1
相关论文
共 50 条
  • [1] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [2] Longitudinal tumor-informed ctDNA assay and patient outcomes in testicular cancer.
    Chehrazi-Raffle, Alex
    Laliotis, George
    Tillu, Neeraja
    Cumarasamy, Shivaram
    Rich, Jordan
    Manage, Kevin
    Sharma, Shruti
    Dutta, Punashi
    Malhotra, Meenakshi
    Elnaggar, Adam
    Liu, Minetta C.
    Rock, Adam
    Dorff, Tanya B.
    Sfakianos, John P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [3] Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
    Chan, Hiu Ting
    Nagayama, Satoshi
    Otaki, Masumi
    Chin, Yoon Ming
    Fukunaga, Yosuke
    Ueno, Masashi
    Nakamura, Yusuke
    Low, Siew-Kee
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [4] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of patients with stages I-III colorectal cancer (CRC).
    Zhou, Jian
    Yang, Jian
    Zhang, Zixiang
    Li, Ye
    Yi, Bin
    Tang, Yuchen
    Li, Dechun
    Li, Xiaozhe
    Peng, Di
    Li, Xi
    Wang, Yang
    Li, Haiyan
    Li, Bing
    Wang, Chenyang
    Zhu, Pengfei
    Chen, Longfei
    Wu, Shuailai
    Fang, Shuai
    Li, Chenxi
    Qiu, Fujun
    Chuai, Shannon
    Zhang, Zhihong
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [5] Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer
    Watanabe, Kazunori
    Nakamura, Toru
    Kimura, Yasutoshi
    Motoya, Masayo
    Kojima, Shigeyuki
    Kuraya, Tomotaka
    Murakami, Takeshi
    Kaneko, Tsukasa
    Shinohara, Yoshihito
    Kitayama, Yosuke
    Fukuda, Keito
    Hatanaka, Kanako C.
    Mitsuhashi, Tomoko
    Pittella-Silva, Fabio
    Yamaguchi, Toshikazu
    Hirano, Satoshi
    Nakamura, Yusuke
    Low, Siew-Kee
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [6] Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.
    Chen, Gong
    Zeng, Yongming
    Feng, Chunzai
    Yang, Jingge
    Cheng, Longqing
    Wang, Hui
    Xia, Ligang
    Jiang, Mei
    Wang, Xiaozhong
    Zeng, Xiaoling
    Tian, Zihan
    Fu, Ning
    Zhang, Xue
    Cao, Wuqiang
    Li, Pansong
    Gao, Wei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 48 - 48
  • [7] Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer.
    Wang, Judy Sing-Zan
    Sausen, Mark
    Parpart-Li, Sonya
    Murphy, Derek M.
    Velculescu, Victor E.
    Wood, Laura D.
    Solt-Linville, Sara
    Sugar, Elizabeth
    Bartlett, Bjarne
    Blair, Cherie
    Dauses, Tianna
    Jaffee, Elizabeth M.
    Hruban, Ralph H.
    Laheru, Dan
    Diaz, Luis A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Tumor-informed patient-specific panel outperforms tumor-naive and tumor-informed fixed panel for circulating tumor DNA (ctDNA)-based postoperative monitoring of non-small cell lung cancer (NSCLC).
    Chen, Kezhong
    Shen, Haifeng
    Wu, Shuailai
    Zhu, Pengfei
    Wang, Chenyang
    Lizaso, Analyn
    Kang, Guannan
    Wang, Yang
    Lv, Juan
    Fang, Shuai
    Wu, Wenjun
    Qiu, Fujun
    Sun, Yuan
    Lu, Qiang
    Zhao, Heng
    Chuai, Shannon
    Yang, Fan
    Zhang, Zhihong
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [9] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).
    Cao, Di
    Wang, Fu-Long
    Li, Cong
    Zhang, Rong-Xin
    Wu, Xiao-Jun
    Li, Liren
    Lu, Zhen-Hai
    Pan, Zhi-Zhong
    Lin, Jun-zhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Li, Min
    Wang, Chenyang
    Li, Xi
    Chen, Gong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 213 - 213
  • [10] Circulating tumor DNA (ctDNA) and disease recurrence in early stage pancreatic cancer
    Gong, Zimu
    Esmail, Abdullah
    Abdelrahim, Maen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)